Homologous and heterologous boosting of the Chadox1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study

Homologous and heterologous boosting of the Chadox1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study

<p><strong>Background: </strong>Ongoing outbreaks of coronavirus disease 2019 (COVID-19) are driven by waning immunity following primary immunizations and emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape vaccine-induced neutralizing...

書目詳細資料
Main Authors:	Costa Clemens, SA, Milan, EP, Sprinz, E, Neto, JC, Pacciarini, F, Li, P, Chen, HL, Smolenov, I, Pollard, A, Clemens, R
格式:	Journal article
語言:	English
出版:	Oxford University Press 2022

相似書籍

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
由: Camilo C. Roa, et al.
出版: (2024-12-01)

Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike
由: Wonyeong Jung, et al.
出版: (2024-01-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
由: Hermosilla, E, et al.
出版: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
由: Eduardo Hermosilla, et al.
出版: (2022-03-01)

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
由: Dong-In Kim, et al.
出版: (2022-11-01)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
由: Guy Cohen, et al.
出版: (2022-11-01)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
由: Wang-Huei Sheng, et al.
出版: (2022-04-01)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
由: Simone Barocci, et al.
出版: (2022-03-01)

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
由: Jaeeun Yoo, et al.
出版: (2023-10-01)

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
由: Kriangkrai Chawansuntati, et al.
出版: (2024-06-01)

Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
由: Zoltán Bánki, et al.
出版: (2022-06-01)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
由: Jaejo Kim, et al.
出版: (2023-02-01)

Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
由: Marija Vukčević, et al.
出版: (2024-12-01)

Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
由: Rujittika Mungmunpuntipantip, et al.
出版: (2023-01-01)

Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
由: Verena Klemis, et al.
出版: (2022-08-01)

Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil
由: Clemens, SAC, et al.
出版: (2022)

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination
由: Hillson, K, et al.
出版: (2021)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
由: Amnuay Kleebayoon, et al.
出版: (2023-05-01)

Response to comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
由: Wang-Huei Sheng, et al.
出版: (2023-01-01)

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
由: Kriangkrai Tawinprai, et al.
出版: (2023-01-01)

Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
由: Porntip Intapiboon, et al.
出版: (2023-02-01)

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
由: Georg M. N. Behrens, et al.
出版: (2022-08-01)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
由: Noopur Bhatnagar, et al.
出版: (2023-07-01)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
由: Aristine Cheng, et al.
出版: (2023-05-01)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations
由: Aristine Cheng, et al.
出版: (2023-05-01)

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study
由: Davide Firinu, et al.
出版: (2021-12-01)

Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine
由: Mohamed S.H. Hassan, et al.
出版: (2024-01-01)

Heterologous Prime-boost COVID-19 Vaccination
由: Vishal R. Tandon, et al.
出版: (2021-10-01)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
由: Qian He, et al.
出版: (2021-01-01)

Comparative Safety and Effectiveness of Heterologous CoronaVac–ChAdOx1 versus Homologous CoronaVac Vaccination in a Real-World Setting: A Retrospective Cohort Study
由: Ayakarn Ruenkham, et al.
出版: (2023-09-01)

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
由: Chiara Agrati, et al.
出版: (2021-11-01)

Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
由: Haoyue Cheng, et al.
出版: (2022-05-01)

Placental Transfer Immunity to the Newborns in a Twin Pregnant Women Vaccinated with Heterologous CoronaVac-ChAdOx1
由: Saipin Pongsatha, et al.
出版: (2023-01-01)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
由: Clemens, SAC, et al.
出版: (2021)

Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting
由: Otávio Melo Espíndola, et al.
出版: (2023-05-01)

Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort
由: Nihad Adnan, et al.
出版: (2024-04-01)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
由: Julia L. Hurwitz, et al.
出版: (2010-02-01)

Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
由: Yasemin Goereci, et al.
出版: (2021-10-01)

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
由: Helen Parry, et al.
出版: (2021-08-01)

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
由: Emanuel Vogel, et al.
出版: (2022-11-01)